{"nct_id":"NCT02425098","title":"Safety and Immunogenicity With Two Different Serotype 2 Potencies of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Adults in Singapore","status":"COMPLETED","status_verified_date":"2019-07","start_date":"2015-06-03","start_date_type":"ACTUAL","primary_completion_date":"2017-09-18","primary_completion_date_type":"ACTUAL","completion_date":"2017-09-18","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["TAK"]}